WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ZVRA past revenue growth

How has ZVRA's revenue growth performed historically?
Company
170.26%
Industry
151.46%
Market
17.61%
ZVRA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZVRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZVRA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZVRA earnings and revenue history

Current Revenue
$27.5M
Current Earnings
-$46.0M
Current Profit Margin
-167.7%

ZVRA Return on Equity

Current Company
-68.4%
Current Industry
-63.5%
Current Market
188%
ZVRA's Return on Equity (-68.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZVRA announces earnings.

ZVRA Return on Assets

Current Company
-35.2%
Current Industry
2.9%
ZVRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZVRA Return on Capital Employed

Current Company
-45.18%
Current Industry
19.5%
ZVRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZVRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZVRA$27.46M-$43.54M-$46.05M+20.93%N/A
CRDF$488.00k-$41.04M-$41.47M+5.22%N/A
ELEV$0.00-$45.64M-$45.70MN/AN/A
ATNM$81.00k-$48.03M-$48.82M-73.39%N/A
CDXS$70.14M-$66.25M-$76.24M+2.97%N/A
View Top Biotech Stocks

ZVRA earnings dates

Next earnings date
May 13, 2024

Zevra Therapeutics Earnings & Revenue FAQ

What were ZVRA's earnings last quarter?

On Invalid Date, Zevra Therapeutics (NASDAQ: ZVRA) reported Q4 2023 earnings per share (EPS) of -$0.40, up 350% year over year. Total Zevra Therapeutics earnings for the quarter were -$15.15 million. In the same quarter last year, Zevra Therapeutics's earnings per share (EPS) was $0.16.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.

What was ZVRA's earnings growth in the past year?

As of Q2 2024, Zevra Therapeutics's earnings has grown year over year. Zevra Therapeutics's earnings in the past year totalled -$46.05 million.

What is ZVRA's earnings date?

Zevra Therapeutics's earnings date is Invalid Date. Add ZVRA to your watchlist to be reminded of ZVRA's next earnings announcement.

What was ZVRA's revenue last quarter?

On Invalid Date, Zevra Therapeutics (NASDAQ: ZVRA) reported Q4 2023 revenue of $13.22 million up 553.66% year over year. In the same quarter last year, Zevra Therapeutics's revenue was $2.02 million.

What was ZVRA's revenue growth in the past year?

As of Q2 2024, Zevra Therapeutics's revenue has grown 170.26% year over year. This is 18.8 percentage points higher than the US Biotechnology industry revenue growth rate of 151.46%. Zevra Therapeutics's revenue in the past year totalled $27.46 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.